Grifols is a global healthcare company that specializes in the production of plasma-derived medicines. The company was founded in 1940 in Barcelona, Spain, and has since grown to become a leading ...
Raleigh News & Observer: Grifols creating 300 new jobs in Clayton after receiving incentive package
Spanish biotechnology company Grifols, which has a large presence in the Triangle, is creating 300 new jobs in Clayton after receiving an incentive package from North Carolina and Johnston County. The ...
CLAYTON, N.C. (WTVD) -- A global healthcare company is expanding its North Carolina operations with a new $351.6 million capital investment, creating 300 jobs. Grifols Therapeutics will construct a ...
Yahoo Finance UK: Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
Recent performance context for Grifols Grifols (BME:GRF) has drawn investor attention after a mixed run, with a modest 1 day gain, a negative move over the past week and month, and a deeper decline ...
Assessing Grifols (BME:GRF) Valuation After Recent Share Price Weakness And Perceived Discount
The Globe and Mail: Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.
Grifols Refinances 2027 Debt and Extends Maturities with Multi-Billion Term Loan B Package
Spanish plasma-derived medicines company Grifols announced that it has successfully completed the refinancing of its 2027 debt maturities through a new credit agreement structured as a Term Loan B ...
The Corner: Grifols plans to make early repayment of €500 million of its 7.5% secured bonds maturing in 2030